Active, not recruitingPhase 2

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

NCT02750358

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Hartford Healthcare Cancer Institute @ Hartford Hospital

Hartford, Connecticut, United States

+11 additional locations

Save this trial

Hartford Healthcare Cancer Institute @ Hartford HospitalHartford, Connecticut, United States
Memorial Sloan Kettering Basking RidgeBasking Ridge, New Jersey, United States
Memorial Sloan Kettering MonmouthMiddletown, New Jersey, United States
Kings County Hopsital CenterBrooklyn, New York, United States
Coney Island HospitalBrooklyn, New York, United States
Woodhull HospitalBrooklyn, New York, United States
Memorial Sloan Kettering CommackCommack, New York, United States
Memorial Sloan Kettering WestchesterHarrison, New York, United States
Queens Hospital CenterJamaica, New York, United States
Memorial Sloan Kettering Cancer CenterNew York, New York, United States
Memorial Sloan Kettering NassauUniondale, New York, United States
Lehigh Valley Health NetworkAllentown, Pennsylvania, United States